Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Hair loss during breast cancer treatment affects each woman differently, influenced by her environment and family.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Spironolactone does not increase the risk of breast cancer recurrence.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Self-care strategies, especially diet and lifestyle changes, help manage cancer treatment symptoms.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Chemotherapy can harm kidneys in breast cancer patients.

Cancer myths can harm treatment and prevention efforts.